News and commentary from the psychiatry world
Mood alterations may be common prodromal feature, case-control study suggests
Colorado is the second state to legalize psilocybin therapy
Treatments led to lower severity scores, meta-analysis suggests
Insurers review patients' progress to see whether they can go to a lower level of care
Completing eight sessions was not associated with decreased risk, however
Canada offers a cautionary tale
Some thought they would lose their board certification
Discussions with young patients and their parents can make a big difference
Health news and commentary gathered by MedPage Today staff
Clinicians need to know they're not alone in their mental health struggles
Cognitive and behavioral therapy boosted physical function in pragmatic trial
Phase III study shows benefit for brexpiprazole and sertraline